Pressure injury (pressure ulcer) prevention and management — the hospital and long-term care facility programs for pressure ulcer prevention through repositioning protocols, pressure redistribution mattresses, and specialized wound dressings — creates important institutional commercial wound care markets, with the Wound Care Market reflecting pressure injury as a commercially significant wound care segment from regulatory reporting requirements and quality payment program financial consequences.

Hospital-acquired pressure injury financial stakes — the CMS's refusal to pay for hospital-acquired Stage 3/4 pressure ulcers (HAC — Hospital Acquired Conditions) creating significant financial incentive for prevention investment. The estimated average cost of treating a hospital-acquired pressure ulcer of twenty-five thousand to fifty thousand dollars combined with the non-payment policy creating the compelling economic argument for prevention product investment.

Prevention product commercial market — the multi-layer foam prophylactic dressings (Mepilex Border Sacrum, Smith+Nephew Allevyn Life) applied to bony prominences (sacrum, heels) as pressure ulcer prevention demonstrating commercial adoption from evidence-based prevention protocol inclusion. These prevention dressings representing the largest volume category in the pressure injury commercial market.

Long-term care pressure ulcer commercial market — the approximately fifteen thousand US nursing facilities managing pressure ulcers in approximately one million residents at risk creating the substantial institutional commercial market. The CMS nursing home quality reporting including pressure ulcer rates creating the institutional quality incentive driving prevention product investment.

Do you think pressure injury prevention programs have achieved sufficient evidence and institutional adoption to significantly reduce pressure ulcer incidence rates, and what commercial implications would significant incidence reduction have for wound care companies?

FAQ

What pressure injury prevention products are commercially significant? Pressure injury prevention products: prevention dressings: Mepilex Border Sacrum (Mölnlycke): evidence-based; significant RCT evidence; most clinically validated; Smith+Nephew Allevyn Life sacral; ConvaTec Foam sacral; heel prevention: Mepilex Border Heel; DermaFoam; specialized boots; pressure redistribution surfaces: hospital mattresses: GROUP 1, GROUP 2, GROUP 3 mattresses (Medicare classification); low air loss; alternating pressure; specialist surfaces (Claros Advanced Wound Care); wheelchairs seating: custom seating; pressure mapping; positioning: wedges; offloading boots (DFU); total contact cast; dermal protection: barrier creams; skin protectants; incontinence-associated dermatitis prevention; combined: pressure injury prevention market approximately $1.5-2.5 billion US; growing from regulatory pressure; HAPU (hospital-acquired pressure ulcer) quality metrics; CMS non-payment policy sustained commercial driver.

What clinical evidence exists for pressure injury prevention dressings? Prevention dressing clinical evidence: Mepilex Border Sacrum: multiple RCTs demonstrating significant reduction in sacral pressure ulcer incidence; Santamaria RCT (2015): seventy-three percent pressure injury reduction in ICU; multiple hospital programs showing thirty to sixty percent reduction; mechanism: mechanical protection; pressure redistribution; microclimate management; heel prevention: comparable evidence in heel pressure injury prevention; clinical adoption: NPUAP/EPUAP clinical practice guidelines recommending foam dressings for prevention; AWMA Australian guidelines; WOCN position statement; nursing home adoption: protocol implementation; bundle approach; positioning plus dressings; combined: evidence grade: Level 1 for foam dressings in prevention; cost-effectiveness demonstrated: prevention dressing cost less than treatment; institutional ROI clear; commercial adoption accelerated by evidence strength.

#WoundCare #PressureUlcer #PressureInjury #WoundPrevention #HAPU #SacralDressing